With nearly two dozen new CF clinical trials planned to begin in 2015, the program is aimed at boosting the capacity of TDN research teams to conduct studies across a wide range of areas, including antibiotics, anti-inflammatories, nutritional therapies and potential drugs targeting the basic defect in CF.
Research coordinators play a vital role at all
The largest CF clinical trials network in the world, the TDN is made up of Foundation-accredited care centers across the country that have expertise in
"
Eligible centers were invited to apply for the new program - called the ARC Award - as part of a competitive renewal process that takes place every two years. The 60 centers selected for the program will receive matching funds from CFFT, the nonprofit drug development affiliate of the CF Foundation, to hire research coordinators, whose sole focus will be on conducting multicenter clinical trials.
Additional Resources
- Find more information about CF clinical trials.
- Visit the CF Foundation’s interactive drug development pipeline.